Startups channel feed – Endpoints News

Startups channel feed

Leap Therapeutics jumps into growing Claudin18.2 field by buying Flame Biosciences

3 years ago

Scoop: Roche-backed startup gives up on CD47, lays off all employees

3 years ago

A Takeda-backed GI and pain biotech quietly shutters

3 years ago

Cambrian's anti-aging mission expands with new fibrotic disease biotech

3 years ago

Scoop: Biotech developing oral Alzheimer's drug is on $50M hunt

3 years ago

Sanofi extends commitment to $750M biotech startup fund

3 years ago

Flame Biosciences searches for future after Novartis flunks on canakinumab

3 years ago

Vertex gets more precise with Arbor in expanded gene editing pact

3 years ago

Jasper scraps pivotal plans but adds a new indication as more biotechs revise pipelines

3 years ago

BioNTech buys out AI partner InstaDeep for $440M in bid to become ‘technology company’

3 years ago

Scoop: Rakuten billionaire lines up $70M for photoimmunotherapy

3 years ago

Updated: New Apple Tree biotech emerges with antibodies that might pair with Amgen, Mirati's KRAS drugs

3 years ago

Novartis offloads neurodevelopmental disorder asset to small Swiss biotech

3 years ago

Synthekine nabs $100M to boost IL-2 programs after rivals hit setbacks

3 years ago

HighTide Therapeutics rides NASH R&D wave with a $107M raise

3 years ago

'Sorry, Escape Bio closed': A neurodegenerative upstart exits bid to rival Biogen-Denali

3 years ago

Scoop: MPM backs a new checkpoint inhibitor biotech in $80M raise

3 years ago

Vividion 2.0? Ben Cravatt and Scripps team form a new chemoproteomics biotech

3 years ago

After disastrous Galapagos deal, Gilead finds new rheumatoid arthritis partner

3 years ago

Scoop: Bing Yao’s ArriVent lining up $145M raise, after $150M debut in 2021

3 years ago

Scoop: J&J-backed Aro Biotherapeutics eyes nine-figure raise with first trial on horizon

3 years ago

Exclusive: In lieu of an IPO in rocky biotech market, Apnimed lines up $80M from existing investors for two PhIII trials

3 years ago

Scoop: To fund Covid-19 nasal vaccine booster, Yale spinout snags Series A

3 years ago

With focus on neglected eye diseases, Opus buys two gene therapies from Iveric Bio

3 years ago

First page Previous page 33 34 353637 38 39 Next page Last page